Vitamin D supplementation in metabolic syndrome
Not Applicable
Recruiting
- Conditions
- Metabolic syndrome.Metabolic syndromeE88.81
- Registration Number
- IRCT20240215061017N1
- Lead Sponsor
- Pak Emirates Military Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Patients satisfying National Cholesterol Education Program Adult Treatment Panel III criteria for metabolic syndrome
Exclusion Criteria
Current use of lipid lowering drugs
Use of vitamin D supplements in the last 6 months
Hypothyroidsim
Pregnancy
Chronic kidney disease stages 3- 5
Cholestatsis
Nephrotic syndrome
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in serum total cholesterol. Timepoint: 8 weeks after intervention. Method of measurement: Laboratory testing.;Changes in serum triglycerides. Timepoint: 8 weeks after intervention. Method of measurement: Laboratory testing.;Changes in high density lipoproteins. Timepoint: 8 weeks after intervention. Method of measurement: Laboratory testing.;Changes in low density lipoproteins. Timepoint: 8 weeks after intervention. Method of measurement: Laboratory testing.
- Secondary Outcome Measures
Name Time Method